A review: advances of resveratrol co-delivery biomaterials-based system in anti-tumor therapy
Journal of Materials Science: Materials in Medicine · 25.11.2025 · 36 (1)
DOI: 10.1007/s10856-025-06968-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Materials Science: Materials in Medicine, online erschienen am 25.11.2025. Verfasst von Huifang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, PR China. Hauptthemen laut MEDLINE: Resveratrol, Biocompatible Materials, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Chengdu University of Traditional Chinese Medicine Greenhouse Talent Program.
Abstract (Originalsprache)
Resveratrol (3,5,4′-trihydroxy-trans-stilbene), a natural polyphenol, has garnered significant attention in oncology for its multifaceted antitumor mechanisms, including apoptosis induction, angiogenesis suppression, and immunomodulation. Despite its therapeutic potential, clinical translation remains constrained by pharmacokinetic limitations such as rapid metabolism, poor aqueous solubility, and low bioavailability. Recent advancements in biomaterial-based co-delivery systems have emerged as a transformative strategy to circumvent these challenges while amplifying tumor-specific cytotoxicity. By integrating resveratrol with chemotherapeutics, photothermal agents, metal complexes, or covalent organic frameworks (COFs), these systems synergistically enhance therapeutic efficacy through improved drug stability, targeted delivery, and stimuli-responsive release. Furthermore, multifunctional platforms combining photothermal ablation, ROS modulation, and immunotherapy exhibit promise in overcoming multidrug resistance and reprogramming immunosuppressive microenvironments. However, critical gaps persist in understanding structure-activity relationships, long-term biosafety profiles, and clinical scalability. This review comprehensively summarizes the current progress in resveratrol co-delivery systems, emphasizing their mechanisms, preclinical outcomes, and technological innovations. Future directions should prioritize interdisciplinary approaches, including AI-driven nanomaterial design, pharmacogenomic stratification, and biomarker-driven clinical trials, to bridge the gap between preclinical promise and therapeutic reality. By harmonizing resveratrol’s phytochemical efficacy with advanced biomaterial engineering, these co-delivery systems hold transformative potential for precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, PR China.
- Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, PR China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, PR China. 80620404@qq.com.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, PR China. Shared_LT@163.com.
Förderung
- The Chengdu University of Traditional Chinese Medicine Greenhouse Talent Program
Zitieren
APA
Yang, H., Wang, Y., Wang, Y., Tang, K., Guo, J., & Li, T. (2025). A review: advances of resveratrol co-delivery biomaterials-based system in anti-tumor therapy. Journal of Materials Science: Materials in Medicine, 36(1). https://doi.org/10.1007/s10856-025-06968-2
Vancouver
Yang H, Wang Y, Wang Y, Tang K, Guo J, Li T. A review: advances of resveratrol co-delivery biomaterials-based system in anti-tumor therapy. Journal of Materials Science: Materials in Medicine. 2025;36(1). doi:10.1007/s10856-025-06968-2
BibTeX
@article{Yang2025,
author = {Yang, Huifang and Wang, Yiran and Wang, Yilin and Tang, Kexin and Guo, Jing and Li, Tong},
title = {A review: advances of resveratrol co-delivery biomaterials-based system in anti-tumor therapy},
journal = {Journal of Materials Science: Materials in Medicine},
year = {2025},
volume = {36},
number = {1},
doi = {10.1007/s10856-025-06968-2}
}
EUVIMED